RhoA/Rho-Kinase Signaling in Vascular Smooth Muscle and Endothelium: Mechanistic Insights and Translational Implications in Hypertension
Open Access
- 16 November 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (11) , 1607
Abstract
The small GTPase RhoA and its downstream effector Rho-kinase (ROCK) have emerged as pivotal regulators of vascular smooth muscle cell (VSMC) contraction, endothelial function, and vascular remodeling. Activation of the RhoA/ROCK pathway enhances calcium (Ca2+) sensitivity by inhibiting myosin light chain phosphatase (MLCP), thereby promoting sustained vascular tone independent of intracellular Ca2+ levels. In endothelial cells (ECs), RhoA/ROCK signaling contributes to nitric oxide (NO) dysregulation, oxidative stress, cytoskeletal reorganization, and inflammatory activation. Cumulative evidence implicates this pathway in the development and progression of hypertension and other cardiovascular diseases, where maladaptive vascular remodeling, VSMC proliferation, and endothelial dysfunction drive increased vascular resistance. Translational studies have identified ROCK inhibitors and indirect modulators such as statins as promising therapeutic strategies. This review integrates recent mechanistic insights into RhoA/ROCK regulation of vascular function with clinical and translational perspectives on targeting this pathway in hypertension.Keywords
Funding Information
- National Institutes of Health (RO1 DK132948)
This publication has 102 references indexed in Scilit:
- Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategiesDrug Delivery and Translational Research, 2025
- Protein Tyrosine Phosphatase regulation by Reactive Oxygen Species2024
- RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formationAtherosclerosis, 2023
- Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular functionAtherosclerosis, 2022
- Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivityCellular and Molecular Life Sciences, 2009
- The role of RhoA and Rho-associated kinase in vascular smooth muscle contractionCurrent Hypertension Reports, 2003
- RhoA/Rho-kinase, vascular changes, and hypertensionCurrent Hypertension Reports, 2001
- Regulation and Functions of Rho-Associated KinaseExperimental Cell Research, 2000
- ROCK‐I and ROCK‐II, two isoforms of Rho‐associated coiled‐coil forming protein serine/threonine kinase in miceFEBS Letters, 1996
- The small GTP‐binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase.The EMBO Journal, 1996